BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27484861)

  • 21. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
    Graber D; Salvayre R; Levade T
    J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells.
    Soga M; Ishitsuka Y; Hamasaki M; Yoneda K; Furuya H; Matsuo M; Ihn H; Fusaki N; Nakamura K; Nakagata N; Endo F; Irie T; Era T
    Stem Cells; 2015 Apr; 33(4):1075-88. PubMed ID: 25522247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation of p.L43_A44delLA in the SMPD1 gene.
    Baskfield A; Li R; Beers J; Zou J; Liu C; Zheng W
    Stem Cell Res; 2019 May; 37():101436. PubMed ID: 31009819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism.
    Breiden B; Sandhoff K
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in
    Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
    Huang W; Cheng YS; Yang S; Swaroop M; Xu M; Huang W; Zheng W
    Exp Cell Res; 2021 Oct; 407(1):112785. PubMed ID: 34411609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solving the secretory acid sphingomyelinase puzzle: Insights from lysosome-mediated parasite invasion and plasma membrane repair.
    Andrews NW
    Cell Microbiol; 2019 Nov; 21(11):e13065. PubMed ID: 31155842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SMPD1 Mutation Update: Database and Comprehensive Analysis of Published and Novel Variants.
    Zampieri S; Filocamo M; Pianta A; Lualdi S; Gort L; Coll MJ; Sinnott R; Geberhiwot T; Bembi B; Dardis A
    Hum Mutat; 2016 Feb; 37(2):139-47. PubMed ID: 26499107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease.
    Kondo Y; Tokumaru H; Ishitsuka Y; Matsumoto T; Taguchi M; Motoyama K; Higashi T; Arima H; Matsuo M; Higaki K; Ohno K; Irie T
    Mol Genet Metab; 2016 Jul; 118(3):214-219. PubMed ID: 27184436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closure.
    Corcelle-Termeau E; Vindeløv SD; Hämälistö S; Mograbi B; Keldsbo A; Bräsen JH; Favaro E; Adam D; Szyniarowski P; Hofman P; Krautwald S; Farkas T; Petersen NH; Rohde M; Linkermann A; Jäättelä M
    Autophagy; 2016 May; 12(5):833-49. PubMed ID: 27070082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
    Levade T; Vidal F; Vermeersch S; Andrieu N; Gatt S; Salvayre R
    Biochim Biophys Acta; 1995 Oct; 1258(3):277-87. PubMed ID: 7548198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells.
    Suchi M; Dinur T; Desnick RJ; Gatt S; Pereira L; Gilboa E; Schuchman EH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3227-31. PubMed ID: 1565614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alleged Detrimental Mutations in the SMPD1 Gene in Patients with Niemann-Pick Disease.
    Rhein C; Mühle C; Kornhuber J; Reichel M
    Int J Mol Sci; 2015 Jun; 16(6):13649-52. PubMed ID: 26084044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Abl Activation Linked to Autophagy-Lysosomal Dysfunction Contributes to Neurological Impairment in Niemann-Pick Type A Disease.
    Marín T; Dulcey AE; Campos F; de la Fuente C; Acuña M; Castro J; Pinto C; Yañez MJ; Cortez C; McGrath DW; Sáez PJ; Gorshkov K; Zheng W; Southall N; Carmo-Fonseca M; Marugán J; Alvarez AR; Zanlungo S
    Front Cell Dev Biol; 2022; 10():844297. PubMed ID: 35399514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A.
    Bu J; Ashe KM; Bringas J; Marshall J; Dodge JC; Cabrera-Salazar MA; Forsayeth J; Schuchman EH; Bankiewicz KS; Cheng SH; Shihabuddin LS; Passini MA
    Mol Ther; 2012 Oct; 20(10):1893-901. PubMed ID: 22828503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation.
    Aldosari MH; de Vries RP; Rodriguez LR; Hesen NA; Beztsinna N; van Kuilenburg ABP; Hollak CEM; Schellekens H; Mastrobattista E
    Eur J Pharm Biopharm; 2019 Apr; 137():185-195. PubMed ID: 30818011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases.
    Kudoh T; Velkoff MA; Wenger DA
    Biochim Biophys Acta; 1983 Nov; 754(1):82-92. PubMed ID: 6626569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann-Pick A mouse.
    Yang WW; Dodge JC; Passini MA; Taksir TV; Griffiths D; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2007 Oct; 207(2):258-66. PubMed ID: 17686472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin.
    Sutrina SL; Chen WW
    Biochim Biophys Acta; 1984 Apr; 793(2):169-79. PubMed ID: 6424713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.